Lobular carcinoma in situ of the breast

Breast Journal

Volumn 5, Issue 5, 1999, Pages 296-303

  Frykberg, Eric R ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

In situ breast cancer; Lobular carcinoma in situ; Noninvasive breast cancer

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CARCINOMA IN SITU; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMOGRAPHY; MASTECTOMY; PROGNOSIS;

EID: 0032857846     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.1999.00002.x     Document Type: Article

References (48)

1. Broders AC. Carcinoma in situ contrasted with benign penetrating epithelium. JAMA 1932-99:1670-74.
2. Rosner D, Bedwani RN, Vana J, Baker HW, Murphy GP. Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg 1980;192: 139-47.
3. Frykberg ER, Bland KI. In situ breast carcinoma. Adv Surg 1993;26:29-72.
4. IS, stage 0) breast carcinoma. In: Bland KI, Copeland EM, eds. The breast: comprehensive management of benign and malignant diseases, 2nd ed. Philadelphia: W.B. Saunders, 1998:1012-43.
5. Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Surg Pathol 1941;19: 74-99.
6. Frykberg ER, Santiago F, Betsill WL, O'Brien PH. Lobular carcinoma in situ of the breast. Surg Gynecol Obstet 1987; 164:285-301.
7. Acosta JA, Greenlee JA, Gubler KD, et al. Surgical margins after needle-localization breast biopsy. Am J Surg 1995; 170:643-46.
8. Bauer TL, Pandelidis SM, Rhoads JE, et al. Mammographically detected carcinoma of the breast. Surg Gynecol Obstet 1991;173:482-86.
9. Bowers GJ, Getz JB, Roettger RH, et al. Nonpalpable breast lesions: association of mammographie abnormalities with diagnosis after needle-directed biopsy. South Med J 1993; 86:748-52.
10. Franceschi D, Crowe J, Zollinger R, et al. Biopsy of the breast for mammographically detected lesions. Surg Gynecol Obstet 1990;172:449-55.
11. Goedde TA, Frykberg ER, Crump JM, et al. The impact of mammography on breast biopsy. Am Surg 1992;58:661-66.
12. Griffen MM, Welling RE. Needle-localized biopsy of the breast. Surg Gynecol Obstet 1990;170:145-48.
13. Hasselgren P-O, Hummel RP, Fieler MA. Breast biopsy with needle localization: influence of age and mammographie features on the rate of malignancy in 350 nonpalpable breast lesions. Surgery 1991;110:623-28.
14. Letton AH, Mason EM, Ramshaw BJ. Twenty-year review of a breast cancer screening project: ninety-five percent survival of patients with nonpalpable cancers. Cancer 1996;77: 104-106.
15. McCreery BR, Frank LG, Frost DB, et al. An analysis of the results of mammographically guided biopsies of the breast. Surg Gynecol Obstet 1991;172:223-26.
16. Meyer JE, Eberlein TJ, Stomper PC, et al. Biopsy of occult breast lesions: analysis of 1261 abnormalities. JAMA 1990;263:2341-43.
17. Miller RS, Aderman RW, Espinosa MH, et al. The early detection of nonpalpable breast carcinoma with needle localization: experience with 500 patients in a community hospital. Am Surg 1992;58:193-98.
18. Opie H, Estes NC, Jewell WR, et al. Breast biopsy for nonpalpable lesions: A worthwhile endeavor? Am Surg 1993; 59:490-94.
19. Papatestas AE, Hermann D, Hermann G, et al. Surgery for nonpalpable breast lesions. Arch Surg 1990;122:399-402.
20. Patton ML, Haith LR, Goldman WT. An improved technique for needle localized biopsy of occult lesions of the breast. Surg Gynecol Obstet 1993;176:25-29.
21. Perdue P, Page D, Nellestein M, et al. Early detection of breast carcinoma: a comparison of palpable and nonpalpable lesions. Surgery 1992;111:656-59.
22. Petrovich JA, Ross DS, Sullivan JW, et al. Mammographic wire localization in diagnosis and treatment of occult carcinoma of the breast. Surg Gynecol Obstet 1989;168:239-43.
23. Roses DF, Mitnick J, Harris MN, et al. The risk of carcinoma in wire localization biopsies for mammographically detected clustered microcalcifications. Surgery 1991;110: 877-86.
24. Rusnak CH, Pengelly DB, Hosie RT, et al. Preoperative needle localization to detect early breast cancer. Am J Surg 1989;157:505-507.
25. Sailors DM, Crabtree JD, Land RL, et al. Needle localization for nonpalpable breast lesions. Am Surg 1994;60:186-89.
26. Bland KI, Menck HR, Scott-Connor CEH, et al. The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83: 1262-73.
27. McDivitt RW, Stewart FW, Berg JW. Tumors of the breast. Washington, DC: Armed Forces Institute of Pathology, 1968:63-85.
28. Rosen PP. Lobular carcinoma in situ and intraductal carcinoma of the breast. Monogr Pathol 1984;25:59-105.
29. Sonnenfeld MR, Frenna TH, Weidner N, Meyer JE. Lobular carcinoma in situ: mammographie-pathologie correlation of results of needle-directed biopsy. Radiology 1991;181: 363-67.
30. Tulusan AH, Egger H, Schneider ML, Willgeroth F. A contribution to the natural history of breast cancer: IV. Lobular carcinoma in situ and its relation to breast cancer. Arch Gynecol 1982;231:219-26.
31. Hutter RVP. The management of patients with lobular carcinoma in situ of the breast. Cancer 1984;53:798-802.
32. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991;15:209-11.
33. Schnitt SJ, Connolly JL, Tavassoli FA, et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992;16:1133-43.
34. Palazzo JP, Hyslop T. Hyperplastic ductal and lobular lesions and carcinomas in situ of the breast: reproducibility of current diagnostic criteria among community and academic based pathologists. Breast J 1998;4:230-37.
35. Dupont W, Pari F, Hartmann W, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993;71:1258-65.
36. Silverberg SG, Plazzo JP, Hyslop T, Moinfar F. Misconception about mammary intraepithelial neoplasia (MIN). Breast J 1999;5:73-77.
37. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978;42:737-69.
38. Rosen PP, Lieberman PH, Braun DW, et al. Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978;2: 225-51.
39. Page DL, Kidd TE, Dupont WD, et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22:1232-39.
40. Ottesen GL, Graversen HP, Blichert-Toft M, et al. Lobular carcinoma in situ of the female breast: short term results of a prospective nationwide study. Am J Surg Pathol 1993;17: 14-21.
41. Carson W, Sanchez-Forgach E, Stomper P, et al. Lobular carcinoma in situ: observation without surgery as an appropriate therapy. Ann Surg Oncol 1994;1:141-46.
42. Zurrida S, Bartoli C, Galimberti V, et al. Interpretation of risk associated with the unexpected finding of lobular carcinoma in situ. Ann Surg Oncol 1996;3:57-61.
43. Gump FE. Lobular carcinoma in situ: pathology and treatment. Surg Clin N Am 1990;70:873-83.
44. Fisher B, Costantino JP, Wickerham L, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998;90:1371-88.
45. Bodian CA, Perzin KH, Lattes R. Lobular neoplasia: long term risk of breast cancer and relation to other factors. Cancer 1996;78:1024-34.
46. Anderson JA. Lobular carcinoma in situ of the breast: an approach to rational treatment. Cancer 1977;39:2597-602.
47. Gump FE. Implications and management of lobular carcinoma in situ of the breast (LCIS). Breast J 1997;3:196-99.
48. Walt AJ, Simon M, Swanson GM. The continuing dilemma of lobular carcinoma in situ. Arch Surg 1992;127: 904-909.